Results 101 to 110 of about 23,157 (220)

Monitoring HIV Antiretroviral Therapy via Aptamer‐Based Measurements in Preclinical Animal Models, in Human Plasma

Advanced Sensor Research
Monitoring the concentration of antiretroviral drugs is critical to ensuring patient adherence to HIV treatment and prevention regimens, which is crucial for drug efficacy. These tools may also be useful for screening samples at blood donation centers to
Jing Li, Vincent Clark, Chen‐Hsu Yu, Karen Scida, Miguel Aller Pellitero, Rolando L. Albarracín Rivera, Wenrui Zhong, Erin Demek, Jeffrey Fountain, J.D. Mahlum, Richard E. Haaland, Gregory V. Carr, Jonathan Sczepanski, Netzahualcóyotl Arroyo‐Currás   +13 more
doaj   +1 more source

Abstracts From AIDS 2026, the 26th International AIDS Conference, 26 – 31 July 2026 Rio de Janeiro, Brazil & virtual

Journal of the International AIDS Society, Volume 29, Issue S4, July 2026.
wiley   +1 more source

Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study

Infectious Diseases and Therapy
Introduction Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) has been increasingly replaced by bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in the treatment of human immunodeficiency virus (HIV) owing to its more ...
Zhikai Wan, Junwei Su, Xueling Zhu, Xiang Liu, Yongzheng Guo, Dairong Xiang, Xiaotang Zhou, Xiaorong Peng, Ran Tao, Qing Cao, Guanjing Lang, Ying Huang, Biao Zhu   +12 more
doaj   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source

Real-world pharmacovigilance of drug-induced osteoporosis: a focus on antiretroviral therapy and toxicological mechanisms in the elderly. [PDF]

Front Pharmacol
Liu X, Gong Y, Liu L, Wang X, Hu K, Song M, Song Y.   +6 more
europepmc   +1 more source

Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens. [PDF]

AIDS
Marcelin AG, Soulie C, Wirden M, Gruber J, Prata Menezes N, Lim T, Barriere G, Descamps D, Charpentier C, Calvez V.   +9 more
europepmc   +1 more source

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. [PDF]

Open Forum Infect Dis
Post FA, Wohl D, Liegeon G, Brar I, Hagins D, Yazdanpanah Y, Avihingsanon A, Liu H, Aizen K, Hindman JT, Gupta S.   +10 more
europepmc   +1 more source

Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention model. [PDF]

J Antimicrob Chemother
Collins LB, Le A, Nicol MR.
europepmc   +1 more source

Antiretroviral therapy switch among Medicare beneficiaries with HIV. [PDF]

J Manag Care Spec Pharm
Christoph MJ, Mordi U, Li S, Guo H, Gong T, Lim T, Park S, Zachry W, Tien PC.   +8 more
europepmc   +1 more source

Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China. [PDF]

Prev Med Rep
Cheng W, Zhang Y, Yang J, Jiang J, Pan X, Chai C, Wang Y.   +6 more
europepmc   +1 more source